Burden of Clostridium difficile on the Healthcare System

por Dubberke, Erik R., Olsen, Margaret A.
Publicado 2012

113 Procedure-specific Surgical Site Infection (SSI) Prevalence Widely Varies within Certain NHSN (National Healthcare Safety Network) Surgery Groups

por Saeed, Mohammed, Dubberke, Erik R., Olsen, Margaret
Publicado 2014

Epidemiology and Microbiology of First Ventricular Assist Device Infection and Their Effect on Outcomes

por Guzman, Merilda Blanco, Vader, Justin, Olsen, Margaret, Dubberke, Erik R
Publicado 2017

Increasing Age Has Limited Impact on Risk of Clostridium difficile Infection in an Elderly Population

por Olsen, Margaret A, Stwalley, Dustin, Demont, Clarisse, Dubberke, Erik R
Publicado 2018

Final Results from a Phase 2b Randomized, Placebo-Controlled Clinical Trial of RBX2660: A Microbiota-Based Drug for the Prevention of Recurrent Clostridioides difficile Infection

por Dubberke, Erik R., Orenstein, Robert, Khanna, Sahil, Guthmueller, Beth, Lee, Christine
Publicado 2022

Effect of fecal microbial transplantation on Clostridioides difficile infection: dysbiosis, metabolites and health related quality of life

por Garey, Kevin W, Feuerstadt, Paul, Dubberke, Erik R, Guo, Amy, Tillotson, Glenn S
Publicado 2023

Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study

por Zilberberg, Marya D, Reske, Kimberly, Olsen, Margaret, Yan, Yan, Dubberke, Erik R
Publicado 2014

752. Costs Attributable to Clostridioides difficile Infection in the Presence of Differential Mortality

por Sahrmann, John, Stwalley, Dustin, Olsen, Margaret A, Yu, Holly, Dubberke, Erik R
Publicado 2021

Increased Incidence and Risk of Septicemia and Urinary Tract Infection After Clostridioides difficile Infection

por Olsen, Margaret A, Keller, Matthew R, Stwalley, Dustin, Yu, Holly, Dubberke, Erik R
Publicado 2023

ICD-9 Codes and Surveillance for Clostridium difficile–associated Disease

por Dubberke, Erik R., Reske, Kimberly A., McDonald, L. Clifford, Fraser, Victoria J.
Publicado 2006

Serological detection of antibodies to the SARS-CoV-2 nucleocapsid protein from dried blood spots

por Dhar, Arko, Ballman, Claire, Roemmich, Brittany L., Dubberke, Erik R., Farnsworth, Christopher W.
Publicado 2022

Healthcare Costs of Clostridioides difficile Infection in Commercially Insured Younger Adults

por Sahrmann, John M, Olsen, Margaret A, Keller, Matthew R, Yu, Holly, Dubberke, Erik R
Publicado 2023

Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach

por Desai, Kamal, Gupta, Swati B., Dubberke, Erik R., Prabhu, Vimalanand S., Browne, Chantelle, Mast, T. Christopher
Publicado 2016

Etiology of Infectious Diarrhea in Patients Tested for Clostridium difficile: If It Isn’t Clostridium difficile, What Is It?

por Kwon, Jennie H, Hink, Tiffany, Reske, Kimberly, Dubberke, Erik R, Burnham, Carey-Ann D
Publicado 2017

678. Changes in the Clostridioides difficile Infection (CDI) Treatment Pattern Pre-Post Clinical Guideline Update in 2021 and Variations across Hospitals

por Dubberke, Erik R, Li, Qinghua, Obi, Engels N, Turzhitsky, Vladimir, Siddiqui, Fakhar, Nathanson, Brian H
Publicado 2023

Quantifying Transmission of Clostridium difficile within and outside Healthcare Settings

por Durham, David P., Olsen, Margaret A., Dubberke, Erik R., Galvani, Alison P., Townsend, Jeffrey P.
Publicado 2016

Comparing intervention strategies for reducing Clostridioides difficile transmission in acute healthcare settings: an agent-based modeling study

por Stephenson, Brittany, Lanzas, Cristina, Lenhart, Suzanne, Ponce, Eduardo, Bintz, Jason, Dubberke, Erik R., Day, Judy
Publicado 2020

1950. Prevention of Recurrent Clostridium difficile at Six Months Following Treatment With Microbiota-Based Therapy RBX2660: Durability Results From a Phase 2 Open-Label Study

por Mische, Sarah, Orenstein, Robert, Dubberke, Erik R, Khanna, Sahil, Hecht, Gail, Dupont, Herbert, Lee, Christine, Blount, Ken
Publicado 2018

15. Real-World Changes in Clostridioides difficile infection (CDI) Treatment Utilization and Clinical Outcomes Associated with Updated 2017 IDSA Guidelines among Medicare Beneficia...

por Dubberke, Erik R, Puckett, Justin T, Obi, Engels N, Kamal-Bahl, Sachin, Desai, Kaushal, Stuart, Bruce, Doshi, Jalpa A
Publicado 2021

Impact of Updated Clinical Practice Guidelines on Outpatient Treatment for Clostridioides difficile Infection and Associated Clinical Outcomes

por Dubberke, Erik R, Puckett, Justin T, Obi, Engels N, Kamal-Bahl, Sachin, Desai, Kaushal, Stuart, Bruce, Doshi, Jalpa A
Publicado 2022